DiaMedica Therapeutics Inc. (DMAC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    DiaMedica Therapeutics In...

    NASDAQ: DMAC · Real-Time Price · USD
    7.09
    -0.19 (-2.61%)
    At close: Sep 12, 2025, 3:59 PM
    7.18
    1.27%
    After-hours: Sep 12, 2025, 06:16 PM EDT

    DiaMedica Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -24.44M -19.38M -13.68M -13.59M
    Depreciation & Amortization
    		 39K 30K 25K 24K
    Stock-Based Compensation
    		 2.08M 1.68M 1.5M 1.56M
    Other Working Capital
    		 1.36M 188K 312K 129K
    Other Non-Cash Items
    		 -1.27M -1.15M 53K 58K
    Deferred Income Tax
    		 n/a n/a n/a 161K
    Change in Working Capital
    		 1.51M 93K 585K -461K
    Operating Cash Flow
    		 -22.08M -18.73M -11.51M -12.25M
    Capital Expenditures
    		 -25K -24K -81K -22K
    Cash Acquisitions
    		 n/a n/a -11.62K 2K
    Purchase of Investments
    		 -50.41M -69.41M -45.68M -69.81M
    Sales Maturities Of Investments
    		 59M 51.13M 57.3M 49.3M
    Other Investing Acitivies
    		 n/a n/a 11.62K n/a
    Investing Cash Flow
    		 8.56M -18.3M 11.54M -20.54M
    Debt Repayment
    		 -9K -6K -6K -6K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 256K n/a n/a 244K
    Financial Cash Flow
    		 11.99M 36.84M -6K 30.09M
    Net Cash Flow
    		 -1.52M -185K 21K -2.7M
    Free Cash Flow
    		 -22.1M -18.75M -11.59M -12.27M

    Add to Watchlist